ArticleJournal of nanobiotechnology2022

Exosome-liposome hybrid nanoparticle codelivery of TP and miR497 conspicuously overcomes chemoresistant ovarian cancer.

Longxia Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.